Report finds 59% of overdose deaths involved stimulants in 2021 to 2024

A study in Health Economics reveals that comprehensive state bans on flavored e-cigarettes may reduce vaping among young adults, but they can also lead to increased use of traditional cigarettes.

Research in Economic Inquiry reveals that Major League Baseball teams appear to manage player injuries differently depending on contract status, with players on temporary contracts missing significantly fewer games due to injury. This suggests that teams may invest less in the long-term health of non-permanent players.

Scientists studying ways of improving motion sickness have found that playing different types of music may help people recover more effectively. Using a specially calibrated driving simulator, they induced car sickness in participants and then played different types of music while they tried to recover. Soft and joyful music produced the best recovery effects, while sad music was less effective than doing nothing at all.

A father's exposure to passive smoking as a child may impair the lifelong lung function of his children, putting them at risk of COPD—a risk that is heightened further if they are childhood passive smokers themselves—finds research published online in the respiratory journal Thorax.

People with learning disabilities progress faster to severe type 2 diabetes and are at greater risk of dying from their condition than people without these disabilities, suggests research published in the journal BMJ Open Diabetes Research & Control.

Medicaid plays a key role for giving people with opioid-use disorder access to treatment, according to a Rutgers Health study. Progress in life-saving treatment for opioid-use disorder with the medication has stalled in the past several years. While some states were able to achieve substantial improvement, others lost ground.

Standard concurrent chemoradiotherapy (CCRT) for cervical cancer achieves disease-free survival (DFS) in approximately 70% of patients with locally advanced disease; however, nearly 30% still experience recurrence or metastasis.

The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance after the 18-month intravenous (IV) phase.

Scientists at CSIRO, Australia's national science agency, have identified a new virus in Australian flying foxes, a discovery that strengthens Australia's preparedness against emerging infectious diseases.

An international team has created the first comprehensive reference measurements for blood vessel stiffness in healthy young people, a step that could give pediatric and adolescent clinics a multi-decade head start in spotting and treating cardiovascular disease risk.

A new generation of CAR T cell therapy is bringing hope in the fight against cancer, targeting not only blood cancers but also solid tumors such as ovarian and breast cancer. Fraunhofer researchers teamed up with the University Hospital of Würzburg to streamline the complicated process of manufacturing these therapies as well. This could make them much more available.

A study published in The Annals of Thoracic Surgery suggests that prenatal detection of congenital heart disease (CHD) has improved in recent years, largely due to advances in ultrasound screening practices.

A comprehensive study shows that California's CA Bridge program has successfully implemented opioid-use disorder treatment services across more than 80% of the state's emergency departments, reaching over 165,000 patients and providing nearly 45,000 instances of buprenorphine treatment from July 2022 through December 2023 alone.

Acute myocardial infarction and acute kidney injury are life-threatening conditions caused by ischemia, resulting from reduced or blocked blood flow to organs. Although early restoration of blood flow improves survival, many patients still develop chronic heart or kidney failure. The mechanisms driving this transition from acute tissue injury to chronic dysfunction remain poorly understood, and effective treatments are lacking.

There's good news and bad news in the world of global health research. The good news is that the gap between what health scientists are studying and the actual worldwide disease burden has narrowed since 1999. That's according to a new study from a global team of health policy researchers, including Georgia Tech's Cassidy R. Sugimoto.

In a new study, researchers from the University of Chicago discovered that zeaxanthin, a plant-derived carotenoid best known for protecting vision, may also act as an immune-boosting compound by strengthening the cancer-fighting activity of immune cells. The findings, which are published in Cell Reports Medicine, highlight the potential of zeaxanthin as a widely available supplement to improve the effectiveness of cancer immunotherapies.

A Mayo Clinic study finds that a shortened, less intense course of radiation and chemotherapy after minimally invasive surgery for HPV-positive oropharyngeal squamous cell carcinoma (HPV+OPSCC) results in less toxicity, substantially lowering the rates of treatment-related side effects while maintaining high cure rates. The findings were published in The Lancet Oncology.

A study in China covering 42,703 families affected by rare diseases across 32 provincial regions of China has established a new diagnosis framework for rare diseases. It offers new hope to millions of patients struggling with delayed or incorrect diagnoses.